Tag: Bureau of Competition

Displaying 1 - 20 of 482 results.

Filtering by content type: Press Release

In its latest action to ensure competition in the nation’s healthcare markets, the FTC announced that Cardinal Health, Inc. has agreed to resolve charges that it illegally monopolized 25 local markets for the sale and distribution of low-energy radiopharmaceuticals and forced hospitals and clinics...
On June 9, 2015, the Federal Trade Commission will host a workshop to examine competition, consumer protection, and economic issues raised by the proliferation of online and mobile peer-to peer business platforms in certain sectors of the economy, often referred to as the “sharing economy.” The...
The U.S. Court of Appeals for the Eleventh Circuit upheld a Federal Trade Commission Decision and Order finding that McWane, Inc., the largest U.S. supplier of ductile iron pipe fittings used in municipal and regional water distribution systems, unlawfully maintained its monopoly in the domestic...
Federal Trade Commission Chairwoman Edith Ramirez released the agency’s 2014 Annual Highlights today, emphasizing the agency’s work to protect consumers and promote competition during the past calendar year.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Novartis AG’s $16 billion acquisition of GlaxoSmithKline’s portfolio of cancer-treatment drugs likely would be anticompetitive.
Federal Trade Commission staff submitted comments to the Office of the National Coordinator for Health Information Technology (ONC), offering guidance on promoting competition, and the privacy and security of consumer data, in ONC’s plan to increase the adoption of interoperable health information...
The Federal Trade Commission has entered into a settlement with Phoebe Putney Health System, Inc., the Hospital Authority of Albany-Dougherty County, and HCA Inc. resolving the Commission’s charge that the Hospital Authority’s acquisition of Palmyra Park Hospital, Inc. from HCA Inc. – which...
Following a public comment period, the Federal Trade Commission has approved an application from Graco Inc. to divest certain liquid finishing businesses and related assets to Carlisle Companies Inc.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Sun Pharmaceutical Industries Ltd.’s $4 billion acquisition of Ranbaxy Laboratories Ltd. would likely be anticompetitive.
Texas-based energy company Par Petroleum Corporation will terminate its storage and throughput rights at a key gasoline terminal in Hawaii, to settle Federal Trade Commission charges that Par’s proposed $107 million acquisition of Koko’oha Investments, Inc.’s wholly-owned subsidiary Mid Pac...
Federal Trade Commission Chairwoman Edith Ramirez today named former Bureau of Competition Director William J. Baer and former Bureau of Consumer Protection Director David C. Vladeck the 2015 recipients of the Miles W. Kirkpatrick Award for Lifetime FTC Achievement, honoring their commitment to...
The Federal Trade Commission today adopted revisions to the agency’s Rules of Practice.
Pharmaceutical companies Impax Laboratories Inc. and CorePharma, LLC have agreed to divest all of CorePharma’s rights and assets to generic pilocarpine tablets and generic ursodiol tablets, in order to settle  Federal Trade Commission charges that Impax’s proposed $700 million acquisition of...

Filtering by content type: Blog Post

Spring has come again, and with it, flocks of antitrust lawyers and economists have returned to Washington, DC for the ABA’s annual Antirust Law Spring Meeting. I have once again prepared the Bureau of Competition’s report on its activities and accomplishments over the past year...
In recent investigations of hospital mergers, the merging parties often make the argument that the acquired firm is flailing, if not outright failing. Thus, the argument goes, the transaction is necessary to keep the acquired hospital in operation. But courts have set stringent...
From time to time, the Commission revises its rules of practice in the interest of fairness, flexibility and efficiency—in other words, to improve the process it relies on for its investigations, studies and adjudicative proceedings. For instance, in 2009, the Commission made...
Some will remember 1976 as the year of the nation’s bicentennial, but it was also the year that Congress gave the antitrust agencies an important tool to prevent harmful mergers before the harm occurs and before the assets and operations of the merging parties are joined in a way...
Recently, I appeared on a panel that discussed the Commission’s recent Section 5 cases.
There is still time to submit public comments on the FTC’s proposal to study the effectiveness of its remedial orders in merger cases. Fifteen years have passed since the Bureau’s previous Divestiture Study, which resulted in a number of important findings that caused the Commission...
Although FTC staff often rely on voluntary requests for information in the early stages of an investigation, the use of official subpoena and civil investigative demands authorized by the Commission is essential to uncover potential law violations, and when necessary, to pursue a law...

Pages